[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fNvRdAFzyBsARznYOe3FiqyTfsbmqKe-sHBR_oPvC0ac":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":45,"rows":52},"Barts & The London NHS Trust",[4],151,false,24,11,38357,2,118,[14,17,20,23,26,28,30,32],{"name":15,"count":16},"Atrial Fibrillation",16,{"name":18,"count":19},"Heart Failure",6,{"name":21,"count":22},"Neuropathic Pain",5,{"name":24,"count":25},"Hypertrophic Cardiomyopathy",3,{"name":27,"count":25},"Low Back Pain",{"name":29,"count":25},"Coronary Artery Disease",{"name":31,"count":25},"Persistent Atrial Fibrillation",{"name":33,"count":25},"Marfan Syndrome",[35,40],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05711849","Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina","2026-08-31","Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells.",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT03572660","Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM","2030-03-31","Bone marrow derived mononuclear cells and G-CSF",[46,47,48,49,50,51],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[53,77,100,127,155,173,201,219,261,298,324,342,368,386,412,439,457,496,525,549,577,602,632,650,675,693,711,737,761,786,812,830,848,866,902,925,949,975,999,1025,1043],{"intervention":44,"totalTrials":54,"cells":55},1,{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":71,"PHASE4":73,"NA":75},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":54,"soonestReadout":43},[63],{"nctId":41,"briefTitle":42,"status":64,"phases":65,"primaryCompletion":43,"completion":43,"start":66,"enrollment":67,"conditions":68,"interventions":70},"ACTIVE_NOT_RECRUITING",[48],"2018-12-24",20,[69],"Dilated Cardiomyopathy",[44],{"trials":72,"activeCount":58},[],{"trials":74,"activeCount":58},[],{"trials":76,"activeCount":58},[],{"intervention":39,"totalTrials":54,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":94,"PHASE4":96,"NA":98},{"trials":80,"activeCount":58},[],{"trials":82,"activeCount":58},[],{"trials":84,"activeCount":54,"soonestReadout":38},[85],{"nctId":36,"briefTitle":37,"status":86,"phases":87,"primaryCompletion":38,"completion":38,"start":88,"enrollment":89,"conditions":90,"interventions":93},"RECRUITING",[48],"2024-03-01",110,[91,92],"Refractory Angina Pectoris","Refractory Angina",[39],{"trials":95,"activeCount":58},[],{"trials":97,"activeCount":58},[],{"trials":99,"activeCount":58},[],{"intervention":101,"totalTrials":54,"cells":102},"Administration of paracetamol",{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":111,"NA":125},{"trials":104,"activeCount":58},[],{"trials":106,"activeCount":58},[],{"trials":108,"activeCount":58},[],{"trials":110,"activeCount":58},[],{"trials":112,"activeCount":58},[113],{"nctId":114,"briefTitle":115,"status":116,"phases":117,"primaryCompletion":118,"completion":119,"start":120,"enrollment":121,"conditions":122,"interventions":124},"NCT01821872","Paracetamol CSF Pharmacokinetics Study","COMPLETED",[50],"2011-08","2011-11","2011-05",30,[123],"Paracetamol",[101],{"trials":126,"activeCount":58},[],{"intervention":128,"totalTrials":54,"cells":129},"Pregabalin",{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":136,"PHASE4":138,"NA":153},{"trials":131,"activeCount":58},[],{"trials":133,"activeCount":58},[],{"trials":135,"activeCount":58},[],{"trials":137,"activeCount":58},[],{"trials":139,"activeCount":58},[140],{"nctId":141,"briefTitle":142,"status":116,"phases":143,"primaryCompletion":144,"completion":144,"start":145,"enrollment":146,"conditions":147,"interventions":151},"NCT01480765","Preventing Pain After Heart Surgery",[50],"2013-03-07","2011-12-12",150,[148,149,150,21],"Pain","Hyperalgesia","Chronic Illness",[128,152],"Ketamine",{"trials":154,"activeCount":58},[],{"intervention":152,"totalTrials":54,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":171},{"trials":158,"activeCount":58},[],{"trials":160,"activeCount":58},[],{"trials":162,"activeCount":58},[],{"trials":164,"activeCount":58},[],{"trials":166,"activeCount":58},[167],{"nctId":141,"briefTitle":142,"status":116,"phases":168,"primaryCompletion":144,"completion":144,"start":145,"enrollment":146,"conditions":169,"interventions":170},[50],[148,149,150,21],[128,152],{"trials":172,"activeCount":58},[],{"intervention":174,"totalTrials":54,"cells":175},"Combined Depo-Medrone and Lidocaine",{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":199},{"trials":177,"activeCount":58},[],{"trials":179,"activeCount":58},[],{"trials":181,"activeCount":58},[],{"trials":183,"activeCount":58},[],{"trials":185,"activeCount":58},[186],{"nctId":187,"briefTitle":188,"status":116,"phases":189,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":194,"interventions":197},"NCT04017741","A Study Investigating the Efficacy of GON Blocks.",[50],"2019-12-31","2020-01-23","2018-02-14",8,[195,196],"Migraine","Chronic Migraine, Headache",[174,198],"Sodium Chloride 0.9% Inj",{"trials":200,"activeCount":58},[],{"intervention":198,"totalTrials":54,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":211,"NA":217},{"trials":204,"activeCount":58},[],{"trials":206,"activeCount":58},[],{"trials":208,"activeCount":58},[],{"trials":210,"activeCount":58},[],{"trials":212,"activeCount":58},[213],{"nctId":187,"briefTitle":188,"status":116,"phases":214,"primaryCompletion":190,"completion":191,"start":192,"enrollment":193,"conditions":215,"interventions":216},[50],[195,196],[174,198],{"trials":218,"activeCount":58},[],{"intervention":220,"totalTrials":11,"cells":221},"Metformin",{"EARLY_PHASE1":222,"PHASE1":224,"PHASE2":226,"PHASE3":244,"PHASE4":257,"NA":259},{"trials":223,"activeCount":58},[],{"trials":225,"activeCount":58},[],{"trials":227,"activeCount":58},[228],{"nctId":229,"briefTitle":230,"status":116,"phases":231,"primaryCompletion":232,"completion":233,"start":234,"enrollment":235,"conditions":236,"interventions":243},"NCT05240274","The POWERED Study: Prophylaxis With Metformin to Prevent PTDM",[48],"2022-05-30","2022-08-30","2019-01-25",60,[237,238,239,240,241,242,220],"Post-transplant Diabetes Mellitus","New Onset Diabetes After Transplant","New Onset Diabetes After Transplantation","Kidney Transplant; Complications","Renal Transplantation","End Stage Renal Disease",[220],{"trials":245,"activeCount":58},[246],{"nctId":247,"briefTitle":248,"status":116,"phases":249,"primaryCompletion":250,"completion":251,"start":252,"enrollment":253,"conditions":254,"interventions":256},"NCT01319994","Prevention of Metabolic Complications of Glucocorticoid Excess",[48,49],"2014-08","2015-01","2012-07",57,[255],"Iatrogenic Cushing Disease",[220],{"trials":258,"activeCount":58},[],{"trials":260,"activeCount":58},[],{"intervention":262,"totalTrials":11,"cells":263},"Potassium",{"EARLY_PHASE1":264,"PHASE1":266,"PHASE2":268,"PHASE3":270,"PHASE4":294,"NA":296},{"trials":265,"activeCount":58},[],{"trials":267,"activeCount":58},[],{"trials":269,"activeCount":58},[],{"trials":271,"activeCount":58},[272,283],{"nctId":273,"briefTitle":274,"status":116,"phases":275,"primaryCompletion":276,"completion":277,"start":278,"enrollment":279,"conditions":280,"interventions":282},"NCT04053816","Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter",[49],"2023-11-22","2024-06-26","2020-10-20",1684,[281],"Arrhythmias, Cardiac",[262],{"nctId":284,"briefTitle":285,"status":116,"phases":286,"primaryCompletion":287,"completion":288,"start":289,"enrollment":290,"conditions":291,"interventions":293},"NCT03195647","Pilot Study for the Tight K Study",[49],"2018-04-24","2018-05-29","2017-08-01",160,[292],"Cardiac Arrythmias",[262],{"trials":295,"activeCount":58},[],{"trials":297,"activeCount":58},[],{"intervention":299,"totalTrials":54,"cells":300},"Cholecalciferol",{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":320,"NA":322},{"trials":302,"activeCount":58},[],{"trials":304,"activeCount":58},[],{"trials":306,"activeCount":58},[],{"trials":308,"activeCount":58},[309],{"nctId":310,"briefTitle":311,"status":116,"phases":312,"primaryCompletion":313,"completion":313,"start":314,"enrollment":315,"conditions":316,"interventions":318},"NCT00419068","Trial of Adjunctive Vitamin D in Tuberculosis Treatment",[49],"2009-09","2007-01",146,[317],"Tuberculosis, Pulmonary",[299,319],"Migliol Placebo Oil",{"trials":321,"activeCount":58},[],{"trials":323,"activeCount":58},[],{"intervention":319,"totalTrials":54,"cells":325},{"EARLY_PHASE1":326,"PHASE1":328,"PHASE2":330,"PHASE3":332,"PHASE4":338,"NA":340},{"trials":327,"activeCount":58},[],{"trials":329,"activeCount":58},[],{"trials":331,"activeCount":58},[],{"trials":333,"activeCount":58},[334],{"nctId":310,"briefTitle":311,"status":116,"phases":335,"primaryCompletion":313,"completion":313,"start":314,"enrollment":315,"conditions":336,"interventions":337},[49],[317],[299,319],{"trials":339,"activeCount":58},[],{"trials":341,"activeCount":58},[],{"intervention":343,"totalTrials":54,"cells":344},"Darbepoetin alpha",{"EARLY_PHASE1":345,"PHASE1":347,"PHASE2":349,"PHASE3":351,"PHASE4":364,"NA":366},{"trials":346,"activeCount":58},[],{"trials":348,"activeCount":58},[],{"trials":350,"activeCount":58},[],{"trials":352,"activeCount":58},[353],{"nctId":354,"briefTitle":355,"status":116,"phases":356,"primaryCompletion":357,"completion":357,"start":358,"enrollment":359,"conditions":360,"interventions":362},"NCT01196715","Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes",[49],"2015-10-31","2010-11-01",360,[361],"Myelodysplastic Syndrome",[343,363],"Filgrastim",{"trials":365,"activeCount":58},[],{"trials":367,"activeCount":58},[],{"intervention":363,"totalTrials":54,"cells":369},{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":382,"NA":384},{"trials":371,"activeCount":58},[],{"trials":373,"activeCount":58},[],{"trials":375,"activeCount":58},[],{"trials":377,"activeCount":58},[378],{"nctId":354,"briefTitle":355,"status":116,"phases":379,"primaryCompletion":357,"completion":357,"start":358,"enrollment":359,"conditions":380,"interventions":381},[49],[361],[343,363],{"trials":383,"activeCount":58},[],{"trials":385,"activeCount":58},[],{"intervention":387,"totalTrials":54,"cells":388},"Granulocyte-colony stimulating factor",{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":408,"NA":410},{"trials":390,"activeCount":58},[],{"trials":392,"activeCount":58},[],{"trials":394,"activeCount":58},[],{"trials":396,"activeCount":58},[397],{"nctId":398,"briefTitle":399,"status":116,"phases":400,"primaryCompletion":401,"completion":402,"start":403,"enrollment":404,"conditions":405,"interventions":407},"NCT00747708","Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure",[48,49],"2012-05","2013-05","2005-08",148,[406],"Chronic Ischaemic Heart Failure",[387],{"trials":409,"activeCount":58},[],{"trials":411,"activeCount":58},[],{"intervention":413,"totalTrials":54,"cells":414},"Melphalan",{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":421,"PHASE4":435,"NA":437},{"trials":416,"activeCount":58},[],{"trials":418,"activeCount":58},[],{"trials":420,"activeCount":58},[],{"trials":422,"activeCount":58},[423],{"nctId":424,"briefTitle":425,"status":426,"phases":427,"primaryCompletion":428,"completion":428,"start":429,"enrollment":430,"conditions":431,"interventions":433},"NCT01907009","A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)","TERMINATED",[48,49],"2016-12-22","2013-01",29,[432],"Castrate Resistant Prostate Cancer",[413,434],"Lenograstim",{"trials":436,"activeCount":58},[],{"trials":438,"activeCount":58},[],{"intervention":434,"totalTrials":54,"cells":440},{"EARLY_PHASE1":441,"PHASE1":443,"PHASE2":445,"PHASE3":447,"PHASE4":453,"NA":455},{"trials":442,"activeCount":58},[],{"trials":444,"activeCount":58},[],{"trials":446,"activeCount":58},[],{"trials":448,"activeCount":58},[449],{"nctId":424,"briefTitle":425,"status":426,"phases":450,"primaryCompletion":428,"completion":428,"start":429,"enrollment":430,"conditions":451,"interventions":452},[48,49],[432],[413,434],{"trials":454,"activeCount":58},[],{"trials":456,"activeCount":58},[],{"intervention":458,"totalTrials":11,"cells":459},"Cisplatin",{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":490,"PHASE4":492,"NA":494},{"trials":461,"activeCount":58},[],{"trials":463,"activeCount":58},[],{"trials":465,"activeCount":58},[466,476],{"nctId":467,"briefTitle":468,"status":116,"phases":469,"primaryCompletion":470,"completion":470,"start":471,"enrollment":472,"conditions":473,"interventions":475},"NCT01230996","Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer",[47,48],"2018-07","2010-07",22,[474],"Locally Advanced Cervical Cancer",[458],{"nctId":477,"briefTitle":478,"status":116,"phases":479,"primaryCompletion":480,"completion":481,"start":482,"enrollment":483,"conditions":484,"interventions":486},"NCT04054362","Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma",[48],"2021-02-08","2025-02-08","2018-11-29",27,[485],"Pancreatic Cancer",[487,458,488,489],"Paclitaxel protein bound","Gemcitabine","Paricalcitol",{"trials":491,"activeCount":58},[],{"trials":493,"activeCount":58},[],{"trials":495,"activeCount":58},[],{"intervention":488,"totalTrials":11,"cells":497},{"EARLY_PHASE1":498,"PHASE1":500,"PHASE2":513,"PHASE3":519,"PHASE4":521,"NA":523},{"trials":499,"activeCount":58},[],{"trials":501,"activeCount":58},[502],{"nctId":503,"briefTitle":504,"status":116,"phases":505,"primaryCompletion":506,"completion":506,"start":507,"enrollment":430,"conditions":508,"interventions":510},"NCT03307148","Stromal TARgeting for PAncreatic Cancer (STAR_PAC)",[47],"2019-03-19","2016-01-15",[509],"Pancreatic Adenocarcinoma",[511,488,512],"ATRA","Nab-paclitaxel",{"trials":514,"activeCount":58},[515],{"nctId":477,"briefTitle":478,"status":116,"phases":516,"primaryCompletion":480,"completion":481,"start":482,"enrollment":483,"conditions":517,"interventions":518},[48],[485],[487,458,488,489],{"trials":520,"activeCount":58},[],{"trials":522,"activeCount":58},[],{"trials":524,"activeCount":58},[],{"intervention":526,"totalTrials":54,"cells":527},"granulocyte colony stimulating factor",{"EARLY_PHASE1":528,"PHASE1":530,"PHASE2":532,"PHASE3":543,"PHASE4":545,"NA":547},{"trials":529,"activeCount":58},[],{"trials":531,"activeCount":58},[],{"trials":533,"activeCount":58},[534],{"nctId":535,"briefTitle":536,"status":116,"phases":537,"primaryCompletion":538,"completion":539,"start":540,"enrollment":235,"conditions":541,"interventions":542},"NCT01302171","Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy",[48],"2012-12","2013-07","2010-08",[69],[526],{"trials":544,"activeCount":58},[],{"trials":546,"activeCount":58},[],{"trials":548,"activeCount":58},[],{"intervention":550,"totalTrials":54,"cells":551},"Sodium Zirconium Cyclosilicate",{"EARLY_PHASE1":552,"PHASE1":554,"PHASE2":556,"PHASE3":571,"PHASE4":573,"NA":575},{"trials":553,"activeCount":58},[],{"trials":555,"activeCount":58},[],{"trials":557,"activeCount":58},[558],{"nctId":559,"briefTitle":560,"status":426,"phases":561,"primaryCompletion":562,"completion":563,"start":564,"enrollment":565,"conditions":566,"interventions":570},"NCT04983979","The ORTIZ Study: Optimising RASi Therapy With SZC",[48],"2023-03-16","2023-05-16","2022-06-17",18,[567,568,569],"CKD","Diabetes Mellitus, Type 2","Hyperkalemia",[550],{"trials":572,"activeCount":58},[],{"trials":574,"activeCount":58},[],{"trials":576,"activeCount":58},[],{"intervention":578,"totalTrials":54,"cells":579},"Combination Chemotherapy",{"EARLY_PHASE1":580,"PHASE1":582,"PHASE2":584,"PHASE3":596,"PHASE4":598,"NA":600},{"trials":581,"activeCount":58},[],{"trials":583,"activeCount":58},[],{"trials":585,"activeCount":58},[586],{"nctId":587,"briefTitle":588,"status":116,"phases":589,"primaryCompletion":590,"completion":590,"start":591,"enrollment":592,"conditions":593,"interventions":595},"NCT01782339","A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis",[48],"2021-05-05","2012-05-01",45,[594],"Germ Cell Tumour",[578],{"trials":597,"activeCount":58},[],{"trials":599,"activeCount":58},[],{"trials":601,"activeCount":58},[],{"intervention":603,"totalTrials":54,"cells":604},"Sodium Nitrite",{"EARLY_PHASE1":605,"PHASE1":607,"PHASE2":609,"PHASE3":626,"PHASE4":628,"NA":630},{"trials":606,"activeCount":58},[],{"trials":608,"activeCount":58},[],{"trials":610,"activeCount":58},[611],{"nctId":612,"briefTitle":613,"status":116,"phases":614,"primaryCompletion":615,"completion":616,"start":617,"enrollment":618,"conditions":619,"interventions":624},"NCT01584453","Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction",[48],"2013-11","2016-01","2012-04",80,[620,621,622,623],"Myocardial Infarction","Reperfusion Injury","Myocardial Ischemia","Cardiovascular Diseases",[603,625],"Sodium Chloride Placebo",{"trials":627,"activeCount":58},[],{"trials":629,"activeCount":58},[],{"trials":631,"activeCount":58},[],{"intervention":625,"totalTrials":54,"cells":633},{"EARLY_PHASE1":634,"PHASE1":636,"PHASE2":638,"PHASE3":644,"PHASE4":646,"NA":648},{"trials":635,"activeCount":58},[],{"trials":637,"activeCount":58},[],{"trials":639,"activeCount":58},[640],{"nctId":612,"briefTitle":613,"status":116,"phases":641,"primaryCompletion":615,"completion":616,"start":617,"enrollment":618,"conditions":642,"interventions":643},[48],[620,621,622,623],[603,625],{"trials":645,"activeCount":58},[],{"trials":647,"activeCount":58},[],{"trials":649,"activeCount":58},[],{"intervention":651,"totalTrials":54,"cells":652},"Carboplatin AUC-10",{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":657,"PHASE3":669,"PHASE4":671,"NA":673},{"trials":654,"activeCount":58},[],{"trials":656,"activeCount":58},[],{"trials":658,"activeCount":58},[659],{"nctId":660,"briefTitle":661,"status":116,"phases":662,"primaryCompletion":663,"completion":663,"start":664,"enrollment":665,"conditions":666,"interventions":668},"NCT02272816","Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma",[48],"2017-10-13","2012-02-13",48,[667],"Metastatic Seminoma",[651],{"trials":670,"activeCount":58},[],{"trials":672,"activeCount":58},[],{"trials":674,"activeCount":58},[],{"intervention":487,"totalTrials":54,"cells":676},{"EARLY_PHASE1":677,"PHASE1":679,"PHASE2":681,"PHASE3":687,"PHASE4":689,"NA":691},{"trials":678,"activeCount":58},[],{"trials":680,"activeCount":58},[],{"trials":682,"activeCount":58},[683],{"nctId":477,"briefTitle":478,"status":116,"phases":684,"primaryCompletion":480,"completion":481,"start":482,"enrollment":483,"conditions":685,"interventions":686},[48],[485],[487,458,488,489],{"trials":688,"activeCount":58},[],{"trials":690,"activeCount":58},[],{"trials":692,"activeCount":58},[],{"intervention":489,"totalTrials":54,"cells":694},{"EARLY_PHASE1":695,"PHASE1":697,"PHASE2":699,"PHASE3":705,"PHASE4":707,"NA":709},{"trials":696,"activeCount":58},[],{"trials":698,"activeCount":58},[],{"trials":700,"activeCount":58},[701],{"nctId":477,"briefTitle":478,"status":116,"phases":702,"primaryCompletion":480,"completion":481,"start":482,"enrollment":483,"conditions":703,"interventions":704},[48],[485],[487,458,488,489],{"trials":706,"activeCount":58},[],{"trials":708,"activeCount":58},[],{"trials":710,"activeCount":58},[],{"intervention":712,"totalTrials":54,"cells":713},"ADI-PEG 20",{"EARLY_PHASE1":714,"PHASE1":716,"PHASE2":718,"PHASE3":731,"PHASE4":733,"NA":735},{"trials":715,"activeCount":58},[],{"trials":717,"activeCount":58},[],{"trials":719,"activeCount":58},[720],{"nctId":721,"briefTitle":722,"status":723,"phases":724,"primaryCompletion":251,"completion":725,"start":726,"enrollment":727,"conditions":728,"interventions":730},"NCT01279967","A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma","UNKNOWN",[48],"2015-03","2011-01",70,[729],"Malignant Pleural Mesothelioma",[712],{"trials":732,"activeCount":58},[],{"trials":734,"activeCount":58},[],{"trials":736,"activeCount":58},[],{"intervention":738,"totalTrials":54,"cells":739},"Aflibercept",{"EARLY_PHASE1":740,"PHASE1":742,"PHASE2":744,"PHASE3":755,"PHASE4":757,"NA":759},{"trials":741,"activeCount":58},[],{"trials":743,"activeCount":58},[],{"trials":745,"activeCount":58},[746],{"nctId":747,"briefTitle":748,"status":749,"phases":750,"primaryCompletion":751,"completion":751,"start":751,"enrollment":58,"conditions":752,"interventions":754},"NCT03264274","Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer","WITHDRAWN",[48],"2017-02-06",[753],"Colorectal Cancer",[738],{"trials":756,"activeCount":58},[],{"trials":758,"activeCount":58},[],{"trials":760,"activeCount":58},[],{"intervention":762,"totalTrials":54,"cells":763},"Triamcinolone acetonide IM",{"EARLY_PHASE1":764,"PHASE1":766,"PHASE2":768,"PHASE3":780,"PHASE4":782,"NA":784},{"trials":765,"activeCount":58},[],{"trials":767,"activeCount":58},[],{"trials":769,"activeCount":58},[770],{"nctId":771,"briefTitle":772,"status":116,"phases":773,"primaryCompletion":774,"completion":774,"start":775,"enrollment":776,"conditions":777,"interventions":779},"NCT07161778","A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer",[48],"2020-09-24","2011-10-19",55,[778],"Castration Resistant Prostate Cancer",[762],{"trials":781,"activeCount":58},[],{"trials":783,"activeCount":58},[],{"trials":785,"activeCount":58},[],{"intervention":787,"totalTrials":54,"cells":788},"Potassium Nitrate",{"EARLY_PHASE1":789,"PHASE1":791,"PHASE2":793,"PHASE3":806,"PHASE4":808,"NA":810},{"trials":790,"activeCount":58},[],{"trials":792,"activeCount":58},[],{"trials":794,"activeCount":58},[795],{"nctId":796,"briefTitle":797,"status":116,"phases":798,"primaryCompletion":232,"completion":232,"start":482,"enrollment":799,"conditions":800,"interventions":804},"NCT03627130","The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy",[48],640,[801,802,803],"Contrast-induced Nephropathy","Acute Kidney Injury","Acute Coronary Syndrome",[787,805],"Potassium Chloride",{"trials":807,"activeCount":58},[],{"trials":809,"activeCount":58},[],{"trials":811,"activeCount":58},[],{"intervention":805,"totalTrials":54,"cells":813},{"EARLY_PHASE1":814,"PHASE1":816,"PHASE2":818,"PHASE3":824,"PHASE4":826,"NA":828},{"trials":815,"activeCount":58},[],{"trials":817,"activeCount":58},[],{"trials":819,"activeCount":58},[820],{"nctId":796,"briefTitle":797,"status":116,"phases":821,"primaryCompletion":232,"completion":232,"start":482,"enrollment":799,"conditions":822,"interventions":823},[48],[801,802,803],[787,805],{"trials":825,"activeCount":58},[],{"trials":827,"activeCount":58},[],{"trials":829,"activeCount":58},[],{"intervention":511,"totalTrials":54,"cells":831},{"EARLY_PHASE1":832,"PHASE1":834,"PHASE2":840,"PHASE3":842,"PHASE4":844,"NA":846},{"trials":833,"activeCount":58},[],{"trials":835,"activeCount":58},[836],{"nctId":503,"briefTitle":504,"status":116,"phases":837,"primaryCompletion":506,"completion":506,"start":507,"enrollment":430,"conditions":838,"interventions":839},[47],[509],[511,488,512],{"trials":841,"activeCount":58},[],{"trials":843,"activeCount":58},[],{"trials":845,"activeCount":58},[],{"trials":847,"activeCount":58},[],{"intervention":512,"totalTrials":54,"cells":849},{"EARLY_PHASE1":850,"PHASE1":852,"PHASE2":858,"PHASE3":860,"PHASE4":862,"NA":864},{"trials":851,"activeCount":58},[],{"trials":853,"activeCount":58},[854],{"nctId":503,"briefTitle":504,"status":116,"phases":855,"primaryCompletion":506,"completion":506,"start":507,"enrollment":430,"conditions":856,"interventions":857},[47],[509],[511,488,512],{"trials":859,"activeCount":58},[],{"trials":861,"activeCount":58},[],{"trials":863,"activeCount":58},[],{"trials":865,"activeCount":58},[],{"intervention":867,"totalTrials":11,"cells":868},"Ergocalciferol",{"EARLY_PHASE1":869,"PHASE1":871,"PHASE2":873,"PHASE3":875,"PHASE4":877,"NA":890},{"trials":870,"activeCount":58},[],{"trials":872,"activeCount":58},[],{"trials":874,"activeCount":58},[],{"trials":876,"activeCount":58},[],{"trials":878,"activeCount":58},[879],{"nctId":880,"briefTitle":881,"status":116,"phases":882,"primaryCompletion":883,"completion":883,"start":884,"enrollment":885,"conditions":886,"interventions":889},"NCT00882401","Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation",[50],"2010-10","2009-04",64,[887,888],"Chronic Kidney Disease","Vitamin D Deficiency",[867],{"trials":891,"activeCount":58},[892],{"nctId":893,"briefTitle":894,"status":116,"phases":895,"completion":896,"start":897,"enrollment":898,"conditions":899,"interventions":901},"NCT00157066","Effects of Vitamin D Supplementation on Antimycobacterial Immunity",[51],"2006-09","2002-12",230,[900],"Tuberculosis",[867],{"intervention":903,"totalTrials":54,"cells":904},"Medical treatment alone",{"EARLY_PHASE1":905,"PHASE1":907,"PHASE2":909,"PHASE3":911,"PHASE4":913,"NA":915},{"trials":906,"activeCount":58},[],{"trials":908,"activeCount":58},[],{"trials":910,"activeCount":58},[],{"trials":912,"activeCount":58},[],{"trials":914,"activeCount":58},[],{"trials":916,"activeCount":58},[917],{"nctId":918,"briefTitle":919,"status":723,"phases":920,"primaryCompletion":921,"completion":921,"start":922,"enrollment":235,"conditions":923,"interventions":924},"NCT01411371","Catheter Ablation Versus Medical Treatment of AF in Heart Failure",[51],"2011-10","2005-03",[15,18],[903],{"intervention":926,"totalTrials":54,"cells":927},"Anti-TNF therapy",{"EARLY_PHASE1":928,"PHASE1":930,"PHASE2":932,"PHASE3":934,"PHASE4":936,"NA":938},{"trials":929,"activeCount":58},[],{"trials":931,"activeCount":58},[],{"trials":933,"activeCount":58},[],{"trials":935,"activeCount":58},[],{"trials":937,"activeCount":58},[],{"trials":939,"activeCount":58},[940],{"nctId":941,"briefTitle":942,"status":723,"phases":943,"primaryCompletion":944,"completion":945,"start":883,"enrollment":8,"conditions":946,"interventions":948},"NCT02528292","Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis",[],"2018-01","2018-04",[947],"Rheumatoid Arthritis",[926],{"intervention":950,"totalTrials":54,"cells":951},"COVID-19 exposure",{"EARLY_PHASE1":952,"PHASE1":954,"PHASE2":956,"PHASE3":958,"PHASE4":960,"NA":962},{"trials":953,"activeCount":58},[],{"trials":955,"activeCount":58},[],{"trials":957,"activeCount":58},[],{"trials":959,"activeCount":58},[],{"trials":961,"activeCount":58},[],{"trials":963,"activeCount":58},[964],{"nctId":965,"briefTitle":966,"status":749,"phases":967,"primaryCompletion":968,"completion":968,"start":969,"enrollment":58,"conditions":970,"interventions":974},"NCT04340921","The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury",[],"2023-04-14","2020-05-14",[971,972,973],"Cardiovascular Disease Acute","Cardiomyopathies","COVID",[950],{"intervention":976,"totalTrials":54,"cells":977},"Preset increase in frusemide dose",{"EARLY_PHASE1":978,"PHASE1":980,"PHASE2":982,"PHASE3":984,"PHASE4":986,"NA":988},{"trials":979,"activeCount":58},[],{"trials":981,"activeCount":58},[],{"trials":983,"activeCount":58},[],{"trials":985,"activeCount":58},[],{"trials":987,"activeCount":58},[],{"trials":989,"activeCount":58},[990],{"nctId":991,"briefTitle":992,"status":116,"phases":993,"primaryCompletion":994,"completion":995,"start":996,"enrollment":618,"conditions":997,"interventions":998},"NCT01320007","Lung Impedance Monitoring In Treatment of Chronic Heart Failure",[51],"2014-10","2014-12","2010-09",[18],[976],{"intervention":1000,"totalTrials":54,"cells":1001},"Envarsus",{"EARLY_PHASE1":1002,"PHASE1":1004,"PHASE2":1006,"PHASE3":1008,"PHASE4":1010,"NA":1012},{"trials":1003,"activeCount":58},[],{"trials":1005,"activeCount":58},[],{"trials":1007,"activeCount":58},[],{"trials":1009,"activeCount":58},[],{"trials":1011,"activeCount":58},[],{"trials":1013,"activeCount":58},[1014],{"nctId":1015,"briefTitle":1016,"status":749,"phases":1017,"primaryCompletion":1018,"completion":1019,"start":1020,"enrollment":58,"conditions":1021,"interventions":1023},"NCT04973982","ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT",[51],"2022-08-01","2022-10-01","2022-01-31",[1022],"Renal Transplant Failure",[1000,1024],"Adoport",{"intervention":1024,"totalTrials":54,"cells":1026},{"EARLY_PHASE1":1027,"PHASE1":1029,"PHASE2":1031,"PHASE3":1033,"PHASE4":1035,"NA":1037},{"trials":1028,"activeCount":58},[],{"trials":1030,"activeCount":58},[],{"trials":1032,"activeCount":58},[],{"trials":1034,"activeCount":58},[],{"trials":1036,"activeCount":58},[],{"trials":1038,"activeCount":58},[1039],{"nctId":1015,"briefTitle":1016,"status":749,"phases":1040,"primaryCompletion":1018,"completion":1019,"start":1020,"enrollment":58,"conditions":1041,"interventions":1042},[51],[1022],[1000,1024],{"intervention":1044,"totalTrials":54,"cells":1045},"DMARD",{"EARLY_PHASE1":1046,"PHASE1":1048,"PHASE2":1050,"PHASE3":1052,"PHASE4":1054,"NA":1056},{"trials":1047,"activeCount":58},[],{"trials":1049,"activeCount":58},[],{"trials":1051,"activeCount":58},[],{"trials":1053,"activeCount":58},[],{"trials":1055,"activeCount":58},[],{"trials":1057,"activeCount":58},[1058],{"nctId":1059,"briefTitle":1060,"status":116,"phases":1061,"primaryCompletion":538,"completion":1062,"start":1063,"enrollment":1064,"conditions":1065,"interventions":1068},"NCT03124225","Ultrasound Utility in Routine Clinical Practise",[],"2013-06","2011-06",258,[1066,1067],"Arthritis, Rheumatoid","Ultrasonography",[1044]]